REX加密股票溢價收益主動型ETF CEPI 深 滬
等待開盤 05-30 09:30:00 美东时间
35.4501
+0.130
+0.37%
華盛通- 最 高35.63
- 今 開35.25
- 成交量 7.61万股
- 最 低 35.185
- 昨 收 35.32
- 總市值 1.08亿
- 52周最高 35.63
- 市盈率 靜 --
- 換手率 2.50%
- 52周最低 24.4856
- 委 比 -84.31%
- 總股本 304.00万
- 歷史最高 35.63
- 量 比 0.98
- 振 幅 1.26%
- 歷史最低 14.1089
- 每 手 1
- 風險率 2.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OpenAI unveils Rosalind Biodefense program for biodefense, pandemic preparedness
OpenAI (OPENAI) said it is launching a program called Rosalind Biodefense to help trusted developers build new biodefense and pandemic preparedness capabilities. The AI start-up backed by Microsoft (M...
05-29 23:49
Dyadic's Applied Biosolutions Unit Collaborates With Scripps Research To Evaluate Monoclonal Antibody And Vaccine Candidates Targeting Hantaviruses, Including Andes Virus
A series of recently reported hantavirus and Ebola cases worldwide have underscored the importance of pandemic preparedness and highlighted the need to improve the speed, scalability, flexibility, and cost-effectiveness
05-28 19:29
Transcript: Valneva Q1 2026 Earnings Conference Call
On Wednesday, Valneva (NASDAQ:VALN) discussed first-quarter financial results d...
05-13 23:51
中国电力建设企业协会：一季度中国清洁能源建设景气指数为106.77 同比下降6.66点 处于较景气区间
5月11日，中国电力建设企业协会发布2026年第一季度中国清洁能源建设景气指数(CEPI)和中国电力建设发展指数(PCDI)。
05-11 15:48
中国电力建设企业协会：一季度中国清洁能源建设景气指数为106.77 同比下降6.66点 处于较景气区间
5月11日，中国电力建设企业协会发布2026年第一季度中国清洁能源建设景气指数(CEPI)和中国电力建设发展指数(PCDI)。
05-11 15:48
Moderna's Legal Hit Steals Spotlight From Strong Sales
MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth and new flu vaccine approvals in 2026.
05-01 22:44
Moderna Reports Q1 2026 Results: Full Earnings Call Transcript
Moderna (NASDAQ:MRNA) reported first-quarter financial results on Friday. The t...
05-01 21:20
BRIEF-Cepi And Samsung Biologics Collaborate To Strengthen Outbreak-Ready Vaccine Production And Global Access
BRIEF-Cepi And Samsung Biologics Collaborate To Strengthen Outbreak-Ready Vaccine Production And Global Access Feb 3 (Reuters) - Samsung Biologics Co Ltd 207940.KS : CEPI AND SAMSUNG BIOLOGICS COLLABORATE TO STRENGTHEN OUTBREAK-READY VACCINE PRODUCTION AND GLOBAL ACCESS Source text: ID:nPn9NK986a Fu
02-03 21:33
